Also found in: Wikipedia.
Related to definiens: shivaree


n. pl. de·fin·i·en·ti·a (-ĕn′shē-ə, -shə)
The word or words serving to define another word or expression, as in a dictionary entry.

[Latin dēfīniēns, present participle of dēfīnīre, to define; see define.]


n, pl definientia (dɪˌfɪnɪˈɛnʃə)
(Linguistics) the word or words used to define or give an account of the meaning of another word, as in a dictionary entry. Compare definiendum
[Latin: defining]


(dɪˈfɪn i ənz)

n., pl. de•fin•i•en•tia (dɪˌfɪn iˈɛn ʃə, -ʃi ə)
an expression that serves as a definition. Compare definiendum.
[1870–75; < Latin dēfīniēns, present participle of dēfīnīre; see define]
Mentioned in ?
References in periodicals archive ?
Definiens, GE Healthcare, Hamamatsu, Leica, Ventana Medical System and Xifin.
In other words, the definition of each definiendum (defined term) L and U necessarily takes the other term as a definiens (definitional parameter).
Quantification of p63, ki67, and FoxJ1 immunohistochemistry was performed automatically using Tissue Studio and Image Miner software from Definiens (Definiens AG, Munich, Germany).
However, the semantic field of "cultural content" definiens is not determined precisely, which hinders operationalization of the theoretical category.
La definicion aqui defendida no es una definicion satisfactoria si es que por definicion entendemos un analisis del definiens.
Philips healthcare, 3DHISTECH, Corista LLC, Definiens AG, Nikon Corporation, Visiopharm and Omnyx.
Following fundamental approaches were adopted for the mapping using Object Based Classification in Definiens Developer(R).
AstraZeneca also completed the acquisition of Definiens, a company
Reversibility does not mean that we do know intuitively at once what the definition is about, but that the definiens may not mean anything else than the concept which is to be defined.
Astrazeneca plc has announced that its global biologics research and development subsidiary, MedImmune, will acquire privately-owned Definiens.
UK drug maker AstraZeneca Plc (LON:AZN) said its global biologics research and development arm MedImmune had struck an agreement to buy Germany-based imaging and data analysis technology firm Definiens for an initial USD150m (EUR120m) plus additional milestone payments.
Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.